Drug Type Antibody |
Synonyms TRIV-920 |
Target |
Mechanism trypsin-1 inhibitors(serine protease 1 inhibitors), trypsin-2 inhibitors(serine protease 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hereditary Pancreatitis | Discovery | US | 03 Oct 2024 |